{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:23:41Z","timestamp":1772720621333,"version":"3.50.1"},"reference-count":96,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1517\/14656566.2013.756867","type":"journal-article","created":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T06:09:31Z","timestamp":1356070171000},"page":"65-77","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacotherapy for pneumococcal infections: an update"],"prefix":"10.1517","volume":"14","author":[{"given":"Susanna","family":"Esposito","sequence":"first","affiliation":[{"name":"Pediatric Clinic 1, Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Principi","sequence":"additional","affiliation":[{"name":"Pediatric Clinic 1, Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,12,21]]},"reference":[{"issue":"3","key":"e_1_3_1_3_1","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1016\/j.vaccine.2011.06.096","article-title":"Pneumococcal disease manifestation in children before and after vaccination: what is new?","volume":"29","author":"Andrade AL","year":"2011","unstructured":"Andrade AL, Toscano CM, Minamisava R, Pneumococcal disease manifestation in children before and after vaccination: what is new? Vaccine 2011;29(Suppl 3):C2-14","journal-title":"Vaccine"},{"key":"e_1_3_1_4_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-0029-1202938","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention","volume":"30","author":"Lynch JP","year":"2009","unstructured":"Lynch JP III, Zhanel GG. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 2009;30:89-209","journal-title":"Semin Respir Crit Care Med"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61204-6"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-51-2-98"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01877-08"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/3.2.254"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1721-1729.2001"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-007-0321-5"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.020016-0"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1586\/eri.09.132"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02726.x"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.05.037"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2008.02031.x"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.12.054"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1086\/649872"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03182.x"},{"issue":"23","key":"e_1_3_1_19_1","first-page":"S1189","article-title":"Resistance among Streptococcus pneumoniae: patterns, mechanisms, interpreting the breakpoints","volume":"6","author":"Brueggemann AB","year":"2000","unstructured":"Brueggemann AB, Doern GV. Resistance among Streptococcus pneumoniae: patterns, mechanisms, interpreting the breakpoints. Am J Manag Care 2000;6(23 Suppl):S1189-96","journal-title":"Am J Manag Care"},{"key":"e_1_3_1_20_1","volume-title":"Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. Document M100-S20","author":"Clinical and Laboratory Standards Institute","year":"2010","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. Document M100-S20. CLSI; Wayne, PA: 2010"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2010.04.013"},{"key":"e_1_3_1_22_1","unstructured":"European Committee on Antimicrobial Susceptibility Testing. EUCAST. 2012.Available from: http:\/\/www.eucast.org\/clinical-breakpoints\/ [Accessed 19 September 2012]"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.6.2101-2107.2004"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2005.12.008"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2012.01.012"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2006.06.006"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.07.137"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2005.04.022"},{"issue":"4","key":"e_1_3_1_29_1","doi-asserted-by":"crossref","first-page":"S322","DOI":"10.1086\/382687","article-title":"Pneumococcal resistance to macrolides, lincosamides, ketolides and streptogramin B agents: molecular mechanisms and resistance phenotypes","volume":"38","author":"Edelstein PH","year":"2004","unstructured":"Edelstein PH. Pneumococcal resistance to macrolides, lincosamides, ketolides and streptogramin B agents: molecular mechanisms and resistance phenotypes. Clin Infect Dis 2004;38(Suppl 4):S322-7","journal-title":"Clin Infect Dis"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000253059.84602.c3"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2005.09.012"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.2894"},{"key":"e_1_3_1_33_1","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1016\/j.vaccine.2006.05.012","article-title":"Active surveillance of Streptococcus pneumoniae bacteremia in Italian children","volume":"24","author":"Tarallo L","year":"2006","unstructured":"Tarallo L, Tancredi F, Schito G, Active surveillance of Streptococcus pneumoniae bacteremia in Italian children. Vaccine 2006;24:6938-43","journal-title":"Vaccine"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3180f610b3"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.2.e23"},{"key":"e_1_3_1_36_1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1542\/peds.99.3.438","article-title":"Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia? A meta-analysis","volume":"99","author":"Rothrock SG","year":"1997","unstructured":"Rothrock SG, Harper MB, Green SM, Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia? A meta-analysis. Pediatrics 1997;99:438-44","journal-title":"Pediatrics"},{"key":"e_1_3_1_37_1","first-page":"217","article-title":"Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines","volume":"16","author":"Lynch JP","year":"2010","unstructured":"Lynch JP III, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 2010;16:217-25","journal-title":"Curr Opin Pulm Med"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408410600822942"},{"key":"e_1_3_1_39_1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/PEC.0b013e31825cfd3e","article-title":"Reduced use of occult bacteremia blood screens by emergency medicine physicians using immunization registry for children presenting with fever without a source","volume":"28","author":"Zeretzke CM","year":"2012","unstructured":"Zeretzke CM, McIntosh MS, Kalynych CJ, Reduced use of occult bacteremia blood screens by emergency medicine physicians using immunization registry for children presenting with fever without a source. Pediatr Emerg Care 2012;28:640-5","journal-title":"Pediatr Emerg Care"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.997-1001.2003"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.9.2375"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.2165\/11530590-000000000-00000"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00070-09"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0800836"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1086\/515003"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.06.018"},{"key":"e_1_3_1_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-010-0110-7"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1086\/425368"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.12.2467"},{"key":"e_1_3_1_50_1","article-title":"Should corticosteroids be used in bacterial meningitis in children?","author":"Esposito S","year":"2012","unstructured":"Esposito S, Semino M, Picciolli I, Principi N. Should corticosteroids be used in bacterial meningitis in children? Eur J Paediatr Neurol 2012; Epub ahead of print","journal-title":"Eur J Paediatr Neurol"},{"key":"e_1_3_1_51_1","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/424467","article-title":"Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact","volume":"190","author":"Rodriguez CA","year":"2004","unstructured":"Rodriguez CA, Atkinson R, Bitar W, Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact. J Infect Dis 2004;190:1481-7","journal-title":"J Infect Dis"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199907000-00004"},{"key":"e_1_3_1_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200201000-00004"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.113.5.1451"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2010.08.016"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199312000-00001"},{"key":"e_1_3_1_57_1","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1086\/514120","article-title":"Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?","volume":"176","author":"Dagan R","year":"1997","unstructured":"Dagan R, Abramson O, Leibovitz E, Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J Infect Dis 1997;176:1253-9","journal-title":"J Infect Dis"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199603000-00015"},{"key":"e_1_3_1_59_1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00006454-199806000-00037","article-title":"Implications of pharmacokinetics in making choices for the management of acute otitis media","volume":"17","author":"Blumer JL","year":"1998","unstructured":"Blumer JL. Implications of pharmacokinetics in making choices for the management of acute otitis media. Pediatr Infect Dis J 1998;17:565-70","journal-title":"Pediatr Infect Dis J"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199707000-00014"},{"key":"e_1_3_1_61_1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.inf.0000065688.21336.fa","article-title":"Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children","volume":"22","author":"Piglansky L","year":"2003","unstructured":"Piglansky L, Leibovitz E, Raiz S, Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Pediatr Infect Dis J 2003;22:405-13","journal-title":"Pediatr Infect Dis J"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.1177\/0009922808319966"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2703"},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1504.071704"},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir1053"},{"key":"e_1_3_1_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328352b60c"},{"issue":"2","key":"e_1_3_1_67_1","first-page":"1","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011","volume":"66","author":"Harris M","year":"2011","unstructured":"Harris M, Clark J, Coote N, British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 2011;66(Suppl 2):1-23","journal-title":"Thorax"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318255dc5b"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir531"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31825384ae"},{"key":"e_1_3_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60564-9"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-010-0928-9"},{"key":"e_1_3_1_73_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01827-10"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.114"},{"key":"e_1_3_1_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-010-1195-6"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00133-06"},{"key":"e_1_3_1_77_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.1.35"},{"key":"e_1_3_1_78_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1202939"},{"key":"e_1_3_1_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508243330802"},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.1.1"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.1086\/377534"},{"key":"e_1_3_1_82_1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1201-9712(01)90031-1","article-title":"Comparative analysis of outcome and clinical features in children with pleural empyema caused by penicillin-nonsusceptible and penicillin-susceptible Streptococcus pneumoniae","volume":"5","author":"Paganini H","year":"2001","unstructured":"Paganini H, Guinazu JR, Hernandez C, Comparative analysis of outcome and clinical features in children with pleural empyema caused by penicillin-nonsusceptible and penicillin-susceptible Streptococcus pneumoniae. Int J Infect Dis 2001;5:86-8","journal-title":"Int J Infect Dis"},{"key":"e_1_3_1_83_1","first-page":"CD004874","article-title":"Antibiotics for community-acquired pneumonia in children","volume":"3","author":"Kabra SK","year":"2010","unstructured":"Kabra SK, Lodha R, Pandey RM. Antibiotics for community-acquired pneumonia in children. Cochrane Database Syst Rev 2010;3:CD004874","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_84_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1086\/520209","article-title":"Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high HIV seroprevalence","volume":"29","author":"Turret GS","year":"1999","unstructured":"Turret GS, Blum S, Fazal BA, Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high HIV seroprevalence. Clin Infect Dis 1999;29:321-7","journal-title":"Clin Infect Dis"},{"key":"e_1_3_1_85_1","doi-asserted-by":"publisher","DOI":"10.1086\/588389"},{"key":"e_1_3_1_86_1","doi-asserted-by":"publisher","DOI":"10.1086\/516340"},{"key":"e_1_3_1_87_1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1542\/peds.99.2.289","article-title":"Therapy for children with invasive pneumococcal infections","volume":"99","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"1997","unstructured":"American Academy of Pediatrics Committee on Infectious Diseases. Therapy for children with invasive pneumococcal infections. Pediatrics 1997;99:289-99","journal-title":"Pediatrics"},{"key":"e_1_3_1_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2010.01.019"},{"key":"e_1_3_1_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2012.02.016"},{"key":"e_1_3_1_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.11.005"},{"issue":"3","key":"e_1_3_1_91_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cid\/cis559","article-title":"Summary of ceftaroline fosemil clinical trial studies and clinical safety","volume":"55","author":"File TM","year":"2012","unstructured":"File TM Jr, Wilmox MH, Stein GE. Summary of ceftaroline fosemil clinical trial studies and clinical safety. Clin Infect Dis 2012;55(S3):173-80","journal-title":"Clin Infect Dis"},{"key":"e_1_3_1_92_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S17433"},{"key":"e_1_3_1_93_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2011.576669"},{"key":"e_1_3_1_94_1","unstructured":"Cohen R Levy C Bingen E Nasopharyngeal carriage in healthy children before and after 13-valent pneumococcal conjugate vaccine implementation [abstract G-1049]. Proceedings of the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy; 9 \u2013 12 September 2012; San Francisco CA"},{"key":"e_1_3_1_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.09.112"},{"key":"e_1_3_1_96_1","unstructured":"Vergison A. Pneumococcal Conjugates: impact of expanded valent vaccines [abstract 439]. Proceedings of the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy; 9 \u2013 12 September 2012; San Francisco CA"},{"key":"e_1_3_1_97_1","unstructured":"Levy C Varon E Bingen E Effect of 7-valent and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in French children under 2 years [abstract G-864]. Proceedings of the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy; 9 \u2013 12 September 2012; San Francisco CA"},{"key":"e_1_3_1_98_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.9.15986"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.2013.756867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T13:07:36Z","timestamp":1772716056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.2013.756867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,21]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1517\/14656566.2013.756867"],"URL":"https:\/\/doi.org\/10.1517\/14656566.2013.756867","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,21]]}}}